# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-25-099382
Filing Date
2025-07-29
Accepted
2025-07-29 07:05:36
Documents
28
Period of Report
2025-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | alks-20250729.htm iXBRL | 8-K | 58765
2 | EX-99.1 | alks-ex99_1.htm | EX-99.1 | 515973
3 | EX-99.2 | alks-ex99_2.htm | EX-99.2 | 15311
4 | GRAPHIC | alks-ex99_2s1.jpg | GRAPHIC | 228957
5 | GRAPHIC | alks-ex99_2s2.jpg | GRAPHIC | 688847
6 | GRAPHIC | alks-ex99_2s3.jpg | GRAPHIC | 120756
7 | GRAPHIC | alks-ex99_2s4.jpg | GRAPHIC | 226675
8 | GRAPHIC | alks-ex99_2s5.jpg | GRAPHIC | 265906
9 | GRAPHIC | alks-ex99_2s6.jpg | GRAPHIC | 246847
10 | GRAPHIC | alks-ex99_2s7.jpg | GRAPHIC | 359040
11 | GRAPHIC | alks-ex99_2s8.jpg | GRAPHIC | 109965
12 | GRAPHIC | alks-ex99_2s9.jpg | GRAPHIC | 281228
13 | GRAPHIC | alks-ex99_2s10.jpg | GRAPHIC | 274635
14 | GRAPHIC | alks-ex99_2s11.jpg | GRAPHIC | 264246
15 | GRAPHIC | alks-ex99_2s12.jpg | GRAPHIC | 97373
16 | GRAPHIC | alks-ex99_2s13.jpg | GRAPHIC | 206068
17 | GRAPHIC | alks-ex99_2s14.jpg | GRAPHIC | 283924
18 | GRAPHIC | alks-ex99_2s15.jpg | GRAPHIC | 239227
19 | GRAPHIC | alks-ex99_2s16.jpg | GRAPHIC | 134333
| Complete submission text file | 0000950170-25-099382.txt |  | 6277156

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alks-20250729.xsd | EX-101.SCH | 30799
31 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20250729_htm.xml | XML | 4683

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 251157507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)